+Compare
HSKA
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
1.31B

HSKA Heska Corp Forecast, Technical & Fundamental Analysis

a manufacturer of animal health products

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for HSKA with price predictions
08:00 PM EDT May 30, 2023

HSKA in +3.63% Uptrend, growing for three consecutive days on May 31, 2023

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HSKA advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where HSKA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 30, 2023. You may want to consider a long position or call options on HSKA as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSKA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HSKA broke above its upper Bollinger Band on May 30, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HSKA entered a downward trend on May 26, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSKA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSKA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.129) is normal, around the industry mean (25.140). P/E Ratio (526.316) is within average values for comparable stocks, (142.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.617). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (4.873) is also within normal values, averaging (51.655).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.29B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 20%. ESMC experienced the highest price growth at 56%, while BIOC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was 67% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 68
Price Growth Rating: 57
SMR Rating: 83
Profit Risk Rating: 85
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

HSKA is expected to report earnings to rise 133.35% to 39 cents per share on August 08

Heska Corp HSKA Stock Earnings Reports
Q2'23
Est.
$0.40
Q1'23
Missed
by $0.10
Q4'22
Beat
by $0.35
Q3'22
Beat
by $0.04
Q2'22
Beat
by $0.06
The last earnings report on May 05 showed earnings per share of 17 cents, missing the estimate of 27 cents. With 160.84K shares outstanding, the current market capitalization sits at 1.31B.
A.I.Advisor
published Dividends

HSKA paid dividends on October 10, 2012

Heska Corp HSKA Stock Dividends
А dividend of $0.10 per share was paid with a record date of October 10, 2012, and an ex-dividend date of September 26, 2012. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of animal health products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3760 Rocky Mountain Avenue
Phone
+1 970 493-7272
Employees
808
Web
https://www.heska.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLJX15.200.03
+0.20%
MFS Global Real Estate R1
LPEFX5.64N/A
N/A
ALPS Global Opportunity Inv
JANBX39.54-0.10
-0.25%
Janus Henderson Balanced D
AWPRX16.87-0.10
-0.59%
AB Sustainable Intl Thematic R
VDSCX16.12-0.21
-1.29%
Victory Diversified Stock C

HSKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSKA has been loosely correlated with WST. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HSKA jumps, then WST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSKA
1D Price
Change %
HSKA100%
+0.03%
WST - HSKA
48%
Loosely correlated
-0.51%
IDXX - HSKA
47%
Loosely correlated
-0.30%
IQV - HSKA
46%
Loosely correlated
-0.88%
RGEN - HSKA
46%
Loosely correlated
-3.11%
PACB - HSKA
45%
Loosely correlated
+0.32%
More

Groups containing HSKA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSKA
1D Price
Change %
HSKA100%
+0.03%
animals
(undefined stocks)
62%
Loosely correlated
+0.43%
playing with pets
(undefined stocks)
57%
Loosely correlated
-0.18%
medical research
(undefined stocks)
55%
Loosely correlated
-0.12%
medical service
(undefined stocks)
54%
Loosely correlated
-0.02%